The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2023 | Modern prognostication in MPNs: improving risk stratification & treatment approaches
Francesco Passamonti, MD, University of Insubria, Varese, Italy, briefly discusses the importance of prognostication in myeloproliferative neoplasms (MPNs), highlighting its role in selecting patients for stem cell transplantation (SCT). This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
